Attitudes and understanding of complementary and alternative medicine in cancer care: An exploratory study of patients’ perspectives in Karachi, Pakistan

Abstract

Objective: To evaluate the prevalence and types of complementary and alternative medicine (CAM) modalities among patients with cancer in Karachi, Pakistan. Methods: This descriptive cross-sectional study was conducted from March 2021 to December 2021. Five hundred patients with cancer were invited to participate in the study. Electronic databases, namely, Google scholar, Publons, EMBASE, PubMed, Chinese National Knowledge Infrastructure Database, and ResearchGate was used for questionnaire designed. The self-administered survey included questions on demographic characteristics, education level, socio-economic conditions and information about CAM therapies, prevalence, effectiveness, and common CAM modalities. Statistical analysis was conducted using SPSS software version 22. Results: Out of the 500 invited patients, 433 (86.6%) successfully completed and returned the questionnaires. In contrast to patients who were with younger, highly educated, professionally active, higher income, and had advanced cancer, time since diagnosis, type of treatment, cancer types and family history are significantly associated with CAM use. The results showed that 59.8% of the participants were acquainted with complementary and/or alternative medicine and considered safe owing to its natural ingredients. The prevalence of CAM usage among cancer patients was 40.9% and the most widely used CAM modality was herbal medicine (27.7%) and dietary supplements (28.8%). Patients used CAM as a complementary therapy to improve the morphological parameter (28.2%), strengthen the immune system (6.8%), and to decrease the side effects of conventional treatment (18.1%). Most of the respondents get the information regarding CAM therapy from the electronic media (43.2%) and the family members (48%) rather than healthcare personnel. Conclusions: Participants used CAM modalities along with the conventional health care practices. Further multicentre studies should be conducted to provide information regarding the usage of CAM therapies and their eventual benefits in patients with cancer.

Keywords

Alternative medicine / Cancer patients / Complementary medicine / Cross-sectional study

References

[1] Asiimwe JB, Nagendrappa PB, Atukunda EC, Kamatenesi MM, Nambozi G, Tolo CU, et al. Prevalence of the use of herbal medicines among patients with cancer: A systematic review and meta-analysis. Evid Based Complement Alternat Med 2021; 2021:9963038. doi: 10.1155/2021/9963038.

[2] Rasheed Z, Al-Rashidy M, Al-Raqibah A, Al-Moqbel A, Al-Bakri A, Al-Harbi A, et al. Experience of cancer patients for the usage of complementary and alternative medicine therapy. Open Access Maced J Med Sci 2020; 8(E):521-527. doi: https://doi.org/10.3889/oamjms.2020.5012.

[3] Kristoffersen AE, Stub T, Broderstad AR, Hansen AH. Use of traditional and complementary medicine among Norwegian cancer patients in the seventh survey of the Tromsø study. BMC Complement Altern Med 2019; 19(1):341.

[4] Kasprzycka K, Kurzawa M, Kucharz M, Godawska M, Oleksa M, Stawowy M, et al. Complementary and alternative medicine use in hospitalized cancer patients-study from Silesia, Poland. Int J Environ Res Public Health 2022; 19(3):1600.

[5] Kanyilmaz G, Akmansu M, Bora H, Yirmibesoglu EE. The use of complementary and alternative medicine among cancer patients treated with radiotherapy. Turk J Oncol 2022; 37(1):74-82.

[6] Jo HG, Seo J, Choi S, Lee D. East Asian herbal medicine to reduce primary pain and adverse events in cancer patients: A systematic review and meta-analysis with association rule mining to identify core herb combination. Front Pharmacol 2022; 12:800571.

[7] Mercadante S, Bellavia G, Cascio AL, Dabbene M, di Silvestre G, Casuccio A, et al. The use of complementary alternative medicines in advanced cancer patients followed at home. Support Care Cancer 2022; 30(3):2003-2008.

[8] Pervez S, Jabbar AA, Haider G, Ashraf S, Qureshi MA, Lateef F, et al. Karachi cancer registry (KCR): Age-standardized incidence rate by age-group and gender in a mega city of Pakistan. Asian Pac J Cancer Prev 2020; 21(11):3251-3258.

[9] Idrees R, Fatima S, Abdul-Ghafar J, Raheem A, Ahmad Z. Cancer prevalence in Pakistan: Meta-analysis of various published studies to determine variation in cancer figures resulting from marked population heterogeneity in different parts of the country. World J Surg Oncol 2018; 16(1):129-139.

[10] Mussarat S, Ali R, Ali S, Mothana RA, Ullah R, Adnan M. Medicinal animals and plants as alternative and complementary medicine in southern regions of Khyber Pakhtunkhwa, Pakistan. Front Pharmacol 2021; 12:649046.

[11] Mwaka AD, Abbo C, Kinengyere AA. Traditional and complementary medicine use among adult cancer patients undergoing conventional treatment in Sub-Saharan Africa: A scoping review on the use, safety and risks. Cancer Manag Res 2020; 12:3699-3712.

[12] Chotipanich A, Sooksrisawat C, Jittiworapan B. Association between complementary and alternative medicine use and prolonged time to conventional treatment among Thai cancer patients in a tertiary-care hospital. PeerJ 2019; 7:e7159.

[13] Wode K, Henriksson R, Sharp L, Stoltenberg A, Hok Nordberg J. Cancer patients’ use of complementary and alternative medicine in Sweden: A cross-sectional study. BMC Complement Altern Med 2019; 19(1):62.

[14] Abuelgasim KA, Alsharhan Y, Alenzi T, Alhazzani A, Ali YZ, Jazieh AR. The use of complementary and alternative medicine by patients with cancer: A cross-sectional survey in Saudi Arabia. BMC Complement Altern Med 2018; 18(1):88.

[15] Albabtain H, Alwhaibi M, Alburaikan K, Asiri Y. Quality of life and complementary and alternative medicine use among women with breast cancer. Saudi Pharm J 2018; 26(3):416-421.

[16] Naja F, Anouti B, Shatila H, Akel R, Haibe Y, Tfayli A. Prevalence and correlates of complementary and alternative medicine use among patients with lung cancer: A cross-sectional study in Beirut, Lebanon. Evid Based Complement Alternat Med 2017; 2017:8434697.